IMGN - ImmunoGen: Strong Catalysts Ahead And Solid Q3 Earnings October, 31 2021 02:21 PM ImmunoGen Inc. ImmunoGen released its Q3-2021 earnings and numbers are solid. Positive expectations around SORAYA study. Stock price far from 52-week high. For further details see: ImmunoGen: Strong Catalysts Ahead And Solid Q3 Earnings